Commercial Information Circulars

24-hour hotline : 23 922 922

e-mail address : enquiry@tid.gov.hk

Ref. ： EIC 631/2/5

22 February 2016

Dear Sirs,

Commercial Information Circular No. 201/2016

The Mainland of China : Notice Concerning Suspending the Implementation of Related Provisions in respect of Electronic Supervision and Administration on Drugs as Stipulated in Notice No. 1/2015

The China Food and Drug Administration issued on 20 February 2016 a notice concerning suspending the implementation of related provisions in respect of electronic supervision and administration on drugs as stipulated in Notice No. 1/2015. Please refer to the Appendix (pdf format) for the notice (available in Chinese only).

2.For details of the "Notice Concerning Issues on Full Implementation of Electronic Supervision and Administration on Drugs by Drug Manufacturing Enterprises and Drug Enterprises", please refer to CIC No. 48/2015 dated 9 January 2015.

ENQUIRIES

3.If you have any questions on the content of the document mentioned in this circular, please contact the issuing authority of the Mainland of China direct. For other questions on this circular, please contact Mainland Branch (I) (tel: 2398 5444) of the Department.

Yours faithfully,
 

(Miss Bonny CHAO)
for Director-General of Trade and Industry

Note: While every effort is made to ensure the accuracy of the above information, the Department cannot guarantee this to be so and will not be held liable for any reliance placed on the same.